Phosphoglucomutase mutants of Escherichia coli K-12.

Recalibrated linkage map of Escherichia coli K-12. Bacteriol Rev (1976) 35.30

Linkage map of Escherichia coli strain K-12. Bacteriol Rev (1972) 24.34

Maltose/maltodextrin system of Escherichia coli: transport, metabolism, and regulation. Microbiol Mol Biol Rev (1998) 4.45

Escherichia coli mutants impaired in maltodextrin transport. J Bacteriol (1979) 3.51

Physiological studies of Escherichia coli strain MG1655: growth defects and apparent cross-regulation of gene expression. J Bacteriol (2003) 3.29

Construction and use of a versatile set of broad-host-range cloning and expression vectors based on the RK2 replicon. Appl Environ Microbiol (1997) 2.49

Multiple regulator gene control of the galactose operon in Escherichia coli K-12. J Bacteriol (1972) 2.33

The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core. J Bacteriol (1994) 2.28

Genetics of xanthan production in Xanthomonas campestris: the xanA and xanB genes are involved in UDP-glucose and GDP-mannose biosynthesis. J Bacteriol (1992) 1.68

Maltotriose is the inducer of the maltose regulon of Escherichia coli. J Bacteriol (1987) 1.63

UDP-glucose is a potential intracellular signal molecule in the control of expression of sigma S and sigma S-dependent genes in Escherichia coli. J Bacteriol (1995) 1.52

Maltose and maltotriose can be formed endogenously in Escherichia coli from glucose and glucose-1-phosphate independently of enzymes of the maltose system. J Bacteriol (1993) 1.49

Molecular cloning and characterization of the pgm gene encoding phosphoglucomutase of Escherichia coli. J Bacteriol (1994) 1.47

Capsule biosynthesis and basic metabolism in Streptococcus pneumoniae are linked through the cellular phosphoglucomutase. J Bacteriol (2000) 1.42

Identification of lipopolysaccharides and phospholipids of Escherichia coli in polyacrylamide gels. J Bacteriol (1977) 1.39

The plastidic phosphoglucomutase from Arabidopsis. A reversible enzyme reaction with an important role in metabolic control. Plant Physiol (2000) 1.31

Streptococcus iniae phosphoglucomutase is a virulence factor and a target for vaccine development. Infect Immun (2005) 1.19

Role for phosphoglucomutase in Vibrio fischeri-Euprymna scolopes symbiosis. J Bacteriol (2002) 1.18

Suppression of polarity of insertion mutations in the gal operon and N mutations in bacteriophage lambda. J Bacteriol (1976) 1.17

Identification of the pgmG gene, encoding a bifunctional protein with phosphoglucomutase and phosphomannomutase activities, in the gellan gum-producing strain Sphingomonas paucimobilis ATCC 31461. Appl Environ Microbiol (2000) 1.11

The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet (2013) 1.09

Requirement for phosphoglucomutase in exopolysaccharide biosynthesis in glucose- and lactose-utilizing Streptococcus thermophilus. Appl Environ Microbiol (2001) 1.09

Glycogen phosphorylase, the product of the glgP Gene, catalyzes glycogen breakdown by removing glucose units from the nonreducing ends in Escherichia coli. J Bacteriol (2006) 1.06

Comparison of the malA regions of Escherichia coli and Klebsiella pneumoniae. J Bacteriol (1986) 0.97

Role of phosphoglucomutase in lipooligosaccharide biosynthesis in Neisseria gonorrhoeae. J Bacteriol (1994) 0.95

Requirements of glucose and incubation under static conditions for optimal colicin E1 induction. Antimicrob Agents Chemother (1977) 0.92

Identification of the Escherichia coli K-12 ybhE gene as pgl, encoding 6-phosphogluconolactonase. J Bacteriol (2004) 0.88

Cloning and characterization of the gene for amylosucrase from Neisseria polysaccharea: production of a linear alpha-1,4-glucan. J Bacteriol (1997) 0.84

Reduced lipopolysaccharide phosphorylation in Escherichia coli lowers the elevated ori/ter ratio in seqA mutants. Mol Microbiol (2009) 0.82

New maltose Blu mutations in Escherichia coli K-12. J Bacteriol (1979) 0.79

Characterization of the GDP-D-mannose biosynthesis pathway in Coxiella burnetii: the initial steps for GDP-β-D-virenose biosynthesis. PLoS One (2011) 0.78

Current linkage map of Escherichia coli. Bacteriol Rev (1970) 16.26

HEREDITARY DEFECTS IN GALACTOSE METABOLISM IN ESCHERICHIA COLI MUTANTS, I. DETERMINATION OF ENZYME ACTIVITIES. Proc Natl Acad Sci U S A (1959) 6.17

Location of the maltose A and B loci on the genetic map of Escherichia coli. J Bacteriol (1966) 5.97

[Amylomaltase of Escherichia coli]. Ann Inst Pasteur (Paris) (1950) 5.31

Biochemical observations on E. coli mutants defective in uridine diphosphoglucose. Proc Natl Acad Sci U S A (1962) 4.02

A new enzymic defect of galactose metabolism in Escherichia coli K-12 mutants. Biochem Biophys Res Commun (1962) 3.80

Genetic analysis of the maltose A region in Escherichia coli. J Bacteriol (1969) 3.52

[Existence in Escherichia coli K 12 of a common regulation of the biosynthesis of bacteriophage receptors and maltose metabolism]. Ann Inst Pasteur (Paris) (1967) 3.33

[Phenotypic expression and genetic localization of mutations affecting maltose metabolism in Escherichia coli K 12]. Ann Inst Pasteur (Paris) (1967) 2.83

A CHEMICAL BASIS FOR THE HOST-INDUCED MODIFICATION OF T-EVEN BACTERIOPHAGES. Proc Natl Acad Sci U S A (1963) 2.73

The galactose operon of E. coli K-12. I. Structural and pleiotropic mutations of the operon. Genetics (1969) 2.29

[Maltodextrin phosphorylase of Escherichia coli]. Eur J Biochem (1967) 2.21

The metabolic basis for masking of receptor-sites on E. coli K-12 for C21, a lipopolysaccharide core-specific phage. Arch Biochem Biophys (1968) 1.98

6-phosphogluconolactonase mutants of Escherichia coli and a maltose blue gene. J Bacteriol (1969) 1.75

MUTATIONS IN ESCHERICHIA COLI THAT AFFECT URIDINE DIPHOSPHATE GLUCOSE PYROPHOSPHORYLASE ACTIVITY AND GALACTOSE FERMENTATION. Biochim Biophys Acta (1963) 1.67

PHOSPHOGLUCOMUTASE. I. PURIFICATION AND PROPERTIES OF PHOSPHOGLUCOMUTASE FROM ESCHERICHIA COLI. J Biol Chem (1964) 1.50

Isotopic effects and inhibition of polysaccharide phosphorylase by 1,5-gluconolactone. Relationship to the catalytic mechanism. Biochemistry (1971) 0.96

The UCSC Genome Browser Database. Nucleic Acids Res (2003) 32.84

Evidence for two functional gal promoters in intact Escherichia coli cells. J Biol Chem (1981) 17.42

Regulation of tumor antigen synthesis by simain virus 40 gene A. J Virol (1975) 9.93

Control of transcription termination. Annu Rev Biochem (1978) 9.24

Positive control of transcription initiation in bacteria. Annu Rev Genet (1984) 8.74

Isolation of the bacteriophage lambda receptor from Escherichia coli. J Bacteriol (1973) 7.67

Cyclic adenosine 5'-monophosphate in Escherichia coli. Bacteriol Rev (1976) 7.55

Transcriptional regulation by cAMP and its receptor protein. Annu Rev Biochem (1993) 6.49

Location of the maltose A and B loci on the genetic map of Escherichia coli. J Bacteriol (1966) 5.97

Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med (2001) 5.48

Dual control for transcription of the galactose operon by cyclic AMP and its receptor protein at two interspersed promoters. Cell (1977) 5.29

Maltose transport in Escherichia coli K12. A comparison of transport kinetics in wild-type and lambda-resistant mutants as measured by fluorescence quenching. Eur J Biochem (1976) 5.25

A role for mRNA secondary structure in the control of translation initiation. Nature (1982) 5.01

Isolation and characterization of conditional lethal mutants of Escherichia coli defective in transcription termination factor rho. Proc Natl Acad Sci U S A (1976) 4.93

Promoter occlusion: transcription through a promoter may inhibit its activity. Cell (1982) 4.43

Bending of DNA by gene-regulatory proteins: construction and use of a DNA bending vector. Gene (1989) 4.41

A family of bacterial regulators homologous to Gal and Lac repressors. J Biol Chem (1992) 4.07

Use of gene fusions to study outer membrane protein localization in Escherichia coli. Proc Natl Acad Sci U S A (1977) 3.78

The adsorption of coliphage lambda to its host: effect of variations in the surface density of receptor and in phage-receptor affinity. J Mol Biol (1976) 3.75

A control element within a structural gene: the gal operon of Escherichia coli. Cell (1983) 3.62

Genetic analysis of the maltose A region in Escherichia coli. J Bacteriol (1969) 3.52

Escherichia coli mutants impaired in maltodextrin transport. J Bacteriol (1979) 3.51

Dominant constitutive mutations in malT, the positive regulator gene of the maltose regulon in Escherichia coli. J Mol Biol (1978) 3.46

A deletion analysis of prophage lambda and adjacent genetic regions. Proc Natl Acad Sci U S A (1968) 3.46

Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation. Lancet (1991) 3.37

Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A (1996) 3.34

[Existence in Escherichia coli K 12 of a common regulation of the biosynthesis of bacteriophage receptors and maltose metabolism]. Ann Inst Pasteur (Paris) (1967) 3.33

Pleiotropic mutations rendering Escherichia coli K-12 resistant to bacteriophage TP1. J Bacteriol (1980) 3.31

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med (1999) 3.13

Patterns of polymorphism and linkage disequilibrium for cystic fibrosis. Genomics (1987) 3.03

Coronary artery bypass grafting: the Society of Thoracic Surgeons National Database experience. Ann Thorac Surg (1994) 3.00

Structure of the malB region in Escherichia coli K12. I. Genetic map of the malK-lamB operon. Mol Gen Genet (1979) 2.99

Glucose effect and the galactose enzymes of Escherichia coli: correlation between glucose inhibition of induction and inducer transport. J Bacteriol (1966) 2.97

Transcription antitermination by bacteriophage lambda N gene product. J Mol Biol (1980) 2.95

Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell (1987) 2.93

Release of polarity in Escherichia coli by gene N of phage lambda: termination and antitermination of transcription. Proc Natl Acad Sci U S A (1974) 2.92

Modulation of the two promoters of the galactose operon of Escherichia coli. Nature (1979) 2.91

[Phenotypic expression and genetic localization of mutations affecting maltose metabolism in Escherichia coli K 12]. Ann Inst Pasteur (Paris) (1967) 2.83

Structure of the malB region in Escherichia coli K12. II. Genetic map of the malE,F,G operon. Mol Gen Genet (1979) 2.83

Effect of Rho on transcription of bacterial operons. Nat New Biol (1973) 2.74

Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet (2001) 2.70

Complementation studies in the maltose-A region of the Escherichia coli K12 genetic map. J Mol Biol (1971) 2.60

malB region in Escherichia coli K-12: characterization of new mutations. J Bacteriol (1974) 2.56

Demonstration of two operator elements in gal: in vitro repressor binding studies. Proc Natl Acad Sci U S A (1984) 2.54

CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet (2001) 2.51

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer. J Clin Oncol (1993) 2.49

Intergration of the receptor for bacteriophage lambda in the outer membrane of Escherichia coli: coupling with cell division. J Bacteriol (1975) 2.47

Mutations that affect lamB gene expression at a posttranscriptional level. Proc Natl Acad Sci U S A (1981) 2.46

Nobel laureates' letter to President Bush. Washington Post (2001) 2.43

Mutations altering the cellular localization of the phage lambda receptor, an Escherichia coli outer membrane protein. Proc Natl Acad Sci U S A (1978) 2.37

Sites of allosteric shift in the structure of the cyclic AMP receptor protein. Cell (1985) 2.36

Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics. Hum Genet (1990) 2.33

Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med (1998) 2.31

The use of gene fusions to study the expression of malT the positive regulator gene of the maltose regulon. J Mol Biol (1979) 2.27

Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest (1999) 2.24

Control of expression of the pyr genes in Salmonella typhimurium: effects of variations in uridine and cytidine nucleotide pools. J Bacteriol (1975) 2.24

[Maltodextrin phosphorylase of Escherichia coli]. Eur J Biochem (1967) 2.21

Sequence information within the lamB genes in required for proper routing of the bacteriophage lambda receptor protein to the outer membrane of Escherichia coli K-12. J Mol Biol (1982) 2.20

Site-specific DNA binding of nuclear factor I: analyses of cellular binding sites. Mol Cell Biol (1985) 2.19

Biotin-requiring mutants of Escherichia coli K-12. J Bacteriol (1967) 2.16

A technique for integrating any DNA fragment into the chromosome of Escherichia coli. Gene (1984) 2.11

The enigma of myelin-associated growth inhibitors in spontaneously regenerating nervous systems. Trends Neurosci (1994) 2.06

Protein Ia and the lamB protein can replace each other in the constitution of an active receptor for the same coliphage. Proc Natl Acad Sci U S A (1978) 2.06

Colicin E2 release: lysis, leakage or secretion? Possible role of a phospholipase. EMBO J (1984) 2.02

Extracellular pullulanase of Klebsiella pneumoniae is a lipoprotein. J Bacteriol (1986) 2.02

A signal sequence is not sufficient to lead beta-galactosidase out of the cytoplasm. Nature (1980) 2.00

Induction of enzymes involed in the catabolism of deoxyribonucleosides and ribonucleosides in Escherichia coli K 12. Eur J Biochem (1971) 1.97

Activation of transcription at specific promoters by glycerol. J Biol Chem (1974) 1.95

Repressor induced site-specific binding of HU for transcriptional regulation. EMBO J (1997) 1.94

Cooperative DNA binding of heterologous proteins: evidence for contact between the cyclic AMP receptor protein and RNA polymerase. Proc Natl Acad Sci U S A (1988) 1.94

Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med (1998) 1.93

Mutations allowing growth on maltose of Escherichia coli K 12 strains with a deleted malT gene. Mol Gen Genet (1971) 1.92

Systematic review of the treatment and prognosis of the odontogenic keratocyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.85

Impact of internal mammary artery conduits on operative mortality in coronary revascularization. Ann Thorac Surg (1994) 1.85

Alcohol dehydrogenase-negative mutants in Drosophila: defects at the structural locus? Genetics (1976) 1.84

On the significance of the retention of ligand by protein. Proc Natl Acad Sci U S A (1975) 1.83

Energy-coupling of the transport system of Escherichia coli dependent on maltose-binding protein. Eur J Biochem (1977) 1.83

Reversible interaction between coliphage lambda and its receptor protein. J Mol Biol (1975) 1.82

Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat (1993) 1.79

Characterization and expression of the structural gene for pullulanase, a maltose-inducible secreted protein of Klebsiella pneumoniae. J Bacteriol (1985) 1.78

Restriction map of the Escherichia coli malA region and identification of the malT product. J Bacteriol (1980) 1.77

How cyclic AMP and its receptor protein act in Escherichia coli. Cell (1982) 1.77

Fractures of the spine in diffuse idiopathic skeletal hyperostosis. Clin Orthop Relat Res (1991) 1.76

Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA (1991) 1.75

Occurrence of the bacteriophage lambda receptor in some enterobacteriaceae. J Virol (1975) 1.74

Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene. Hum Mutat (1997) 1.74

Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc Natl Acad Sci U S A (1996) 1.73

Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain. J Biol Chem (1988) 1.73

Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut (2005) 1.72

Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med (1996) 1.72

The galactose regulon of Escherichia coli. Mol Microbiol (1993) 1.72

Characterization of Erwinia chrysanthemi extracellular proteases: cloning and expression of the protease genes in Escherichia coli. J Bacteriol (1987) 1.71

DNA looping in cellular repression of transcription of the galactose operon. Genes Dev (1990) 1.70

Magnetic resonance image-directed stereotactic neurosurgery: use of image fusion with computerized tomography to enhance spatial accuracy. J Neurosurg (1995) 1.70

The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet (1998) 1.67

Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol (1977) 1.66

Rapid and sensitive detection of Leishmania kinetoplast DNA from spleen and blood samples of kala-azar patients. Parasitology (1992) 1.65

Control of gal transcription through DNA looping: inhibition of the initial transcribing complex. Proc Natl Acad Sci U S A (1992) 1.65

Histone-like protein HU as a specific transcriptional regulator: co-factor role in repression of gal transcription by GAL repressor. Genes Cells (1996) 1.65

Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64